N-/2-HYDROXY-3-(1-PIPERIDINYL) PROPOXY/PYRIDINE-1-OXIDE-3- CARBOXIMIDOYL CHLORIDE AND ITS USE IN THE TREATMENT OF INSULIN RESISTANCE

N-{2-hidroksi-3-(1-piperidinil)-propoksi}-piridin-1-oksid-3-karboksiimidoil hlorid, njegovi stereoizomeri, i adicione soli sa kiselinama. Prijava sadrži još 3 patentna zahteva. N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NAGY KAROLY, SZILBEREKY JENO, NAGY MELINDA, NAGY ZOLTAN, UROGDI LASZLO, KOMAROMI ANDRAS, CSAKAI ZITA, KURTHY MARIA, MARVANYOS EDE, BARABAS MIHALY, KORANYI LASZLO, MOGYOROSI TAMAS, KARDOS MIHALYNE, TOROK MAGDOLNA, BIRO KATALIN
Format: Patent
Sprache:eng ; srp
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:N-{2-hidroksi-3-(1-piperidinil)-propoksi}-piridin-1-oksid-3-karboksiimidoil hlorid, njegovi stereoizomeri, i adicione soli sa kiselinama. Prijava sadrži još 3 patentna zahteva. N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.